- Question from Jill: I am BRCA positive and I have heard that the PARP inhibitor (ICEBERG) trials are showing success. Do you have any additional information on the current trial or the upcoming trial at NIH where they will combine the PARP inhibitor with chemo?
- Answers - Larry Norton, M.D. The PARP inhibitors are one of the promising treatments for breast cancer and other cancers, and might make sense for people with the breast cancer that commonly arises in women who have a defect in BRCA1. That type of breast cancer is called triple-negative breast cancer because it is negative for estrogen receptor, progesterone receptor, and HER2. The best way to find out if you are eligible for any of the trials with any PARP inhibitors is to go to www.clinicaltrials.gov or call 1-800-4-CANCER.
The Ask-the-Expert Online Conference called Living With Metastatic Breast Cancer featured Larry Norton, M.D. and moderator Marisa Weiss, M.D. answering your questions about managing day-to-day life with metastatic breast cancer.
Editor's Note: This conference took place in October 2007.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.